CD36 and breast carcinoma: While overall CD36 expression levels did not show a significant correlation with overall survival (OS), relapse‐free survival, and distant metastasis‐free survival in breast cancer patients (Figure S1B), a positive correlation was observed in TNBC subtypes (Figure S1C–F).